In conclusion, we demonstrate that NAT10-mediated ac4C modification enables DKK2 to reshape the regulation of cholesterol metabolism by impairing CD8+ T cell functions and facilitating CRC progression. Here, DKK2 is linked to colorectal carcinoma.